Peter J. Hulick

This study identifies ARID5B mutations as a cause of a neurodevelopmental syndrome with neuroinflammation episodes and describes clinical and functional consequences.

This study examines the association between pharmacogenetic drug interactions and 90-day hospital readmissions, finding a 33% increased risk after adjusting for demographic and clinical factors.

This study evaluates a population genetic screening program mediated by primary care physicians, finding actionable variants in nearly 8% of patients and suggesting its potential to improve preventative care.